Overexpression of MiR-128 Specifically Inhibits the Truncated Isoform of NTRK3 and Upregulates BCL2 in SH-SY5Y Neuroblastoma Cells
Overview
Authors
Affiliations
Background: Neurotrophins and their receptors are key molecules in the regulation of neuronal differentiation and survival. They mediate the survival of neurons during development and adulthood and are implicated in synaptic plasticity. The human neurotrophin-3 receptor gene NTRK3 yields two major isoforms, a full-length kinase-active form and a truncated non-catalytic form, which activates a specific pathway affecting membrane remodeling and cytoskeletal reorganization. The two variants present non-overlapping 3'UTRs, indicating that they might be differentially regulated at the post-transcriptional level. Here, we provide evidence that the two isoforms of NTRK3 are targeted by different sets of microRNAs, small non-coding RNAs that play an important regulatory role in the nervous system.
Results: We identify one microRNA (miR-151-3p) that represses the full-length isoform of NTRK3 and four microRNAs (miR-128, miR-485-3p, miR-765 and miR-768-5p) that repress the truncated isoform. In particular, we show that the overexpression of miR-128 - a brain enriched miRNA - causes morphological changes in SH-SY5Y neuroblastoma cells similar to those observed using an siRNA specifically directed against truncated NTRK3, as well as a significant increase in cell number. Accordingly, transcriptome analysis of cells transfected with miR-128 revealed an alteration of the expression of genes implicated in cytoskeletal organization as well as genes involved in apoptosis, cell survival and proliferation, including the anti-apoptotic factor BCL2.
Conclusions: Our results show that the regulation of NTRK3 by microRNAs is isoform-specific and suggest that neurotrophin-mediated processes are strongly linked to microRNA-dependent mechanisms. In addition, these findings open new perspectives for the study of the physiological role of miR-128 and its possible involvement in cell death/survival processes.
iModEst: disentangling -omic impacts on gene expression variation across genes and tissues.
Sokolowski D, Mai M, Verma A, Morgenshtern G, Subasri V, Naveed H NAR Genom Bioinform. 2025; 7(1):lqaf011.
PMID: 40041206 PMC: 11879402. DOI: 10.1093/nargab/lqaf011.
The Effect of MiR320a on Lung Cancer.
Hasani A Microrna. 2024; 13(3):167-174.
PMID: 38963099 DOI: 10.2174/0122115366296148240530072346.
The Role of miR-128 in Neurodegenerative Diseases.
Lanza M, Cuzzocrea S, Oddo S, Esposito E, Casili G Int J Mol Sci. 2023; 24(7).
PMID: 37046996 PMC: 10093830. DOI: 10.3390/ijms24076024.
Kopcho S, McDew-White M, Naushad W, Mohan M, Okeoma C Viruses. 2023; 15(3).
PMID: 36992331 PMC: 10059597. DOI: 10.3390/v15030622.
The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy.
Setia Budi H, Younus L, Hadi Lafta M, Parveen S, Mohammad H, Al-Qaim Z Front Oncol. 2023; 12:1067974.
PMID: 36793341 PMC: 9923359. DOI: 10.3389/fonc.2022.1067974.